North America Veterinary Healthcare Market Segmented By Veterinary Disease Types, By Animal Types & By Geography - Trends & Forecasts (2017 - 2022)

The North America veterinary market is slated to grow at a healthy CAGR of 5.79% to reach USD 9,511million by 2020 from USD 6,786 million in 2014.



The US and Canada are the two major markets in North Americaveterinary healthcare market. The demand for animal health products in the US is forecasted to increase by XX% annually to reach USD XX billion in 2016.



North America Veterinary Healthcare Market- Market Dynamics



The Canadian Animal Health Institute (CAHI) is a national association whose members are responsible for the sales of approximately XX% of the animal health products in Canada. Sales by CAHI member companies in 2010 were approximately USD XX million. Growing awareness about the diseases in livestock is steadily bringing the importance of animal healthcare to the fore.



Drivers



Some of the many factors discussed in the report that drive the market towards growth are:





Increase in pet ownership

Improved nutrition

Intensifying consumer focus on food safety

Growing awareness about livestock diseases





Restraints



Increased competition for cultivated land and cost-effective production are the hurdles faced by the North America veterinary healthcare market.



The report provides an exhaustive coverage of the market with multi-level segmentation by animal species (farm animals and companion animals), type of healthcare products (vaccines, parasiticides, anti-invectives, medicinal feed additives, and other pharmaceuticals) and geography. Regional coverage includes a study of the animal healthcare markets in the US and Canada.



Some of the key players in the market are:





Bayer Healthcare

Boehringer Ingelheim

Ceva Animal Health, Inc.

Elanco

Merck

Merial (Animal Health Division of Sanofi)

Virbac





What the Report Offers





Market definition for North Americaveterinary healthcare market along with identification of key drivers and restraints for the market.

Market analysis for North Americaveterinary healthcare market, with region-specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.

Identification and analysis of the macro and micro factors that affect the North America veterinary healthcare market on both global and regional scale

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.



1. INTRODUCTION



1.1 Market Definition



1.2 Market Recent Trends



2 Market Analysis



2.1 Market Animal Health Products



2.2 Animal medicines vs. human Medicines



3. Market Dynamics



3.1 Market Drivers



3.1.1 Increase in pet ownership



3.1.2 Improved Nutrition



3.1.3 Intensifying consumer focus on food safety



3.1.4 Greater Livestock production



3.1.5 Increasing Zoonotic and Foodborne Diseases



3.2 Market Constraints



3.2 1 Scarcity of arable land and water



3.2.2 Increased competition for cultivated land



3.2.3 Cost-effective production



3.3 Porter's Five Force Analysis



3.3.1 Threat of New Entrant



3.3.2 Internal Rivalry



3.3.3 Buyer bargaining power



3.3.4 Supplier bargaining power



3.3.5 Threat of substitutes



4. North America Veterinary healthcare Market Segmentation- Animal Types, based on products



4.1 Companion Animal health



4.1.1 Vaccines



4.1.2 Parasiticides



4.1.3 Anti-Infectives



4.1.4 Medicinal Feed Additives



4.1.5 Other Pharmaceuticals



4.2 Farm Animals



4.2.1 Vaccines



4.2.2 Parasiticides



4.2.3 Anti-Infectives



4.2.4 Medicinal Feed additives



4.2.5 Other Pharmaceuticals



5. North America Veterinary Diagnostics Market



5.1 Enzyme Linked Immuno Sorbent Assay (ELISA)



5.2 Rapid Immuno Migration (RIM)



5.3 Agar gel Immuno Diffusion (AGID)



6. North America Veterinary Genetics Market



6.1 HD 50K for Angus



6.2 CLARIFIDE ? for Dairy



6.3 Sheep 50K



6.4 CLARIFIDE ? for Nelore



6.5 Others



7. North America Veterinary Healthcare Market Segmentation- By Animal Species



7.1 Farm animal



7.1.1 Cattle



7.1.2 Swine



7.1.3 Poultry



7.1.4 Fish



7.1.5 Sheep



7.2 Companion Animals



7.2.1 Dogs



7.2.2 Cats



7.2.3 Horses



8. North America Veterinary healthcare market- Country-level Analysis



8.1 US



8.2 Mexico



8.3 Canada



9. Competitive landscape



9.1 Major players in the market



9.2 Mergers and acquisitions



9.3 New product launches



9.4 Agreement, Collaborations, and Partnerships



9.5 Recommendations for New players



9.6 Recommendations for Existing Players



10. Company profiles



10.1 Zoetis animal healthcare



10.1.1 Financial Overview



10.1.2 Business overview



10.1.3 Business strategies



10.2 Merck



10.2.1 Financial Overview



10.2.2 Business overview



10.2.3 Business strategies



10.3 Merial (Animal Health Division of Sanofi)



10.3.1 Financial Overview



10.3.2 Business overview



10.3.3 Business strategies



10.4 Elanco



10.4.1 Financial Overview



10.4.2 Business overview



10.4.3 Business strategies



10.5 Bayer healthcare



10.5.1 Financial Overview



10.5.2 Business overview



10.5.3 Business strategies



10.6 Ceva Animal Health, Inc.



10.6.1 Financial Overview



10.6.2 Business overview



10.6.3 Business strategies



10.7 Virbac



10.7.1 Financial Overview



10.7.2 Business overview



10.7.3 Business strategies



10.8 Boehringer Ingelheim



10.8.1 Financial Overview



10.8.1 Business overview



10.8.1 Business strategies



11. Appendix



11.1. Abbreviations



11.2. Sources



11.3. Bibliography



11.4. Disclaimer

Content are not available

Choose License Type